LivaNova (LIVN)
(Delayed Data from NSDQ)
$53.19 USD
-0.48 (-0.89%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.19 USD
-0.48 (-0.89%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Zacks News
LivaNova (LIVN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 3.92% and 2.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TransMedics (TMDX) delivered earnings and revenue surprises of -28.13% and 26.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Lags Q1 Earnings Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of -7.69% and 3.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 14% and 2.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Can LivaNova (LIVN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
LivaNova (LIVN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Accuray (ARAY) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Accuray (ARAY) delivered earnings and revenue surprises of -100% and 10.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 51.11% and 3.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
LivaNova (LIVN) has been struggling lately, but the selling pressure may be coming to an end soon.
LivaNova (LIVN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 62.50% and 9.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 133.33% and 6.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Tops Q4 Earnings Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 7.58% and -0.73%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: LivaNova (LIVN) Q4 Earnings Expected to Decline
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 80.95% and 8.29%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: LivaNova (LIVN) Q3 Earnings Expected to Decline
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
LivaNova (LIVN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 50.00% and 6.10%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate LivaNova (LIVN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) Lags Q1 Earnings Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of -2.94% and 3.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate LivaNova (LIVN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) Q4 Earnings Top Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 5.26% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Q3 Earnings Surpass Estimates
by Zacks Equity Research
LivaNova (LIVN) delivered earnings and revenue surprises of 16.67% and -1.55%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Medical Products' Oct 30 Earnings Roster: MCK, MASI & More
by Zacks Equity Research
Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have driven the performance of the players in the medical products space this earnings season.
Analysts Estimate LivaNova (LIVN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.